Post by Engr. Olusola Adedayo (@Moschino)

The WHO has prequalified Coartem® (artemether-lumefantrine) Baby, the first malaria treatment developed specifically for newborns and infants weighing 2–5 kg. Developed by Novartis and Medicines for Malaria Venture (MMV),

0 likes · 0 comments · 0 shares